Position in ABBV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,255,246
-$350,040 QoQ
Shares Held
33,359
+0.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Ascent Group, LLC holds $68,984,188 across 14 Drug Manufacturers - General names. ABBV ranks #4 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
68,802 | $16,817,958 | |
| 2 | LLY |
ELI LILLY & Co
|
17,302 | $15,913,856 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
62,184 | $8,666,581 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
33,359 | $7,255,246 | |
| 5 | PFE |
Pfizer Inc
|
184,580 | $5,183,005 | |
| 6 | MRK |
Merck & Co., Inc.
|
37,190 | $4,473,583 | |
| 7 | AMGN |
Amgen Inc
|
7,925 | $2,788,410 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
38,067 | $2,308,762 |
All Filings in ABBV
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,255,246 | 33,359 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $7,605,286 | 33,285 | Shares | Other | 2026-01-20 | |
| 2025-09-30 | $7,469,708 | 32,261 | Shares | Other | 2025-10-20 | |
| 2025-06-30 | $4,013,287 | 21,621 | Shares | Other | 2025-07-21 | |
| 2025-03-31 | $5,149,160 | 24,576 | Shares | Other | 2025-05-16 | |
| 2024-12-31 | $4,608,827 | 25,936 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $4,847,541 | 24,547 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,421,442 | 25,778 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $4,493,499 | 24,676 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,617,288 | 16,889 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,246,334 | 15,070 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,079,523 | 22,857 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,442,392 | 21,600 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,605,272 | 9,933 | Shares | Sole | 2023-02-17 | |
| 2022-09-30 | $1,202,521 | 8,960 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $640,208 | 4,180 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $523,777 | 3,231 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $404,169 | 2,985 | Shares | Sole | 2022-03-01 | |
| No filing history on record for this holder in this stock. | ||||||